The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity

被引：0
|
作者：
Lonnie P. Swift
Suzanne M. Cutts
Abraham Nudelman
Inessa Levovich
Ada Rephaeli
Don R. Phillips
机构：
[1] La Trobe University,Department of Biochemistry
[2] Bar Ilan University,Chemistry Department
[3] Tel Aviv University,Felsenstein Medical Research Center, Sackler School of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Sobuzoxane; Doxorubicin; Formaldehyde; Topoisomerase II; Drug-DNA adducts;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：739 / 749
页数：10
相关论文
共 3 条
  • [1] The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity
    Swift, Lonnie P.
    Cutts, Suzanne M.
    Nudelman, Abraham
    Levovich, Inessa
    Rephaeli, Ada
    Phillips, Don R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (05) : 739 - 749
  • [2] Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death
    Swift, Lonnie P.
    Rephaeli, Ada
    Nudelman, Abraham
    Phillips, Don R.
    Cutts, Suzanne M.
    CANCER RESEARCH, 2006, 66 (09) : 4863 - 4871
  • [3] 2-[4-(7-chloro-2-quinoxalinyloxyphenoxy]-propionic acid (XK469), an inhibitor of topoisomerase (Topo) IIβ, up-regulates Topo IIα and enhances topo IIα-mediated cytotoxicity
    Mensah-Osman, EJ
    Al-Katib, AM
    Wu, HY
    Osman, NI
    Mohammad, RM
    MOLECULAR CANCER THERAPEUTICS, 2002, 1 (14) : 1321 - 1326
1